The research, conducted on human cells, mice, and human lung cancer tissues, revealed that when ISG15 conjugates to SIRT1, it boosts SIRT1’s activity, encouraging tumor growth and reducing the effectiveness of a chemotherapy drug. The gene discussed is ISG15; the disease is lung carcinoma.